BIA submission to the HMT Patient Capital Review
The BIA has responded to the Treasury's Patient Capital Review consutlation, Financing growth in innovative firms. The BIA welcomed the government’s proposal to establish a new National Investment Fund to support the growth of innovative UK bioscience companies.
The BIA also called for:
- Incentives, regulatory changes and a communications campaign to encourage pension funds to back the UK’s innovative industries
- Support to expand the number of UK-based fund managers with expertise in the life sciences
- Tax incentives to encourage greater investment in scaling businesses
- A new Investor Visa Fund to channel money from high-net worth individuals emigrating to the UK into innovative growing companies